FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3216963370> ?p ?o ?g. }

• W3216963370 endingPage "e002953" @default.
• W3216963370 startingPage "e002953" @default.
• W3216963370 abstract "Background BO-112 is a nanoplexed form of polyinosinic:polycytidylic acid that acting on toll-like receptor 3 (TLR3), melanoma differentiation-associated protein 5 (MDA5) and protein kinase RNA-activated (PKR) elicits rejection of directly injected transplanted tumors, but has only modest efficacy against distant untreated tumors. Its clinical activity has also been documented in early phase clinical trials. The 5,6-dimethylxanthenone-4-acetic acid (DMXAA) stimulator of interferon genes (STING) agonist shows a comparable pattern of efficacy when used via intratumoral injections. Methods Mice subcutaneously engrafted with bilateral MC38 and B16.OVA-derived tumors were treated with proinflammatory immunotherapy agents known to be active when intratumorally delivered. The combination of BO-112 and DMXAA was chosen given its excellent efficacy and the requirements for antitumor effects were studied on selective depletion of immune cell types and in gene-modified mouse strains lacking basic leucine zipper ATF-like transcription factor 3 (BATF3), interferon-α/β receptor (IFNAR) or STING. Spatial requirements for the injections were studied in mice bearing three tumor lesions. Results BO-112 and DMXAA when co-injected in one of the lesions of mice bearing concomitant bilateral tumors frequently achieved complete local and distant antitumor efficacy. Synergistic effects were contingent on CD8 T cell lymphocytes and dependent on conventional type 1 dendritic cells, responsiveness to type I interferon (IFN) and STING function in the tumor-bearing host. Efficacy was preserved even if BO-112 and DMXAA were injected in separate lesions in a manner able to control another untreated third-party tumor. Efficacy could be further enhanced on concurrent PD-1 blockade. Conclusion Clinically feasible co-injections of BO-112 and a STING agonist attain synergistic efficacy able to eradicate distant untreated tumor lesions." @default.
• W3216963370 created "2021-12-06" @default.
• W3216963370 creator A5002953299 @default.
• W3216963370 creator A5023079672 @default.
• W3216963370 creator A5025411417 @default.
• W3216963370 creator A5029243551 @default.
• W3216963370 creator A5029398481 @default.
• W3216963370 creator A5039064555 @default.
• W3216963370 creator A5046450040 @default.
• W3216963370 creator A5048677608 @default.
• W3216963370 creator A5049602786 @default.
• W3216963370 creator A5051545190 @default.
• W3216963370 creator A5059491624 @default.
• W3216963370 creator A5063974312 @default.
• W3216963370 creator A5064778193 @default.
• W3216963370 creator A5065123693 @default.
• W3216963370 creator A5065666671 @default.
• W3216963370 creator A5088139094 @default.
• W3216963370 creator A5088679346 @default.
• W3216963370 date "2021-11-01" @default.
• W3216963370 modified "2023-10-17" @default.
• W3216963370 title "Intratumoral co-injection of the poly I:C-derivative BO-112 and a STING agonist synergize to achieve local and distant anti-tumor efficacy" @default.
• W3216963370 cites W1898887656 @default.
• W3216963370 cites W1905337938 @default.
• W3216963370 cites W1963585483 @default.
• W3216963370 cites W2016525911 @default.
• W3216963370 cites W2039730154 @default.
• W3216963370 cites W2042699075 @default.
• W3216963370 cites W2044757050 @default.
• W3216963370 cites W2046505430 @default.
• W3216963370 cites W2053433376 @default.
• W3216963370 cites W2091018161 @default.
• W3216963370 cites W2101173536 @default.
• W3216963370 cites W2109347785 @default.
• W3216963370 cites W2128799252 @default.
• W3216963370 cites W2131271579 @default.
• W3216963370 cites W2132413371 @default.
• W3216963370 cites W2146488455 @default.
• W3216963370 cites W2146512944 @default.
• W3216963370 cites W2150098469 @default.
• W3216963370 cites W2152281757 @default.
• W3216963370 cites W2152347367 @default.
• W3216963370 cites W2157730228 @default.
• W3216963370 cites W2169456326 @default.
• W3216963370 cites W2170612601 @default.
• W3216963370 cites W2563952505 @default.
• W3216963370 cites W2591862469 @default.
• W3216963370 cites W2773106490 @default.
• W3216963370 cites W2791483720 @default.
• W3216963370 cites W2809886276 @default.
• W3216963370 cites W2888914203 @default.
• W3216963370 cites W2889117947 @default.
• W3216963370 cites W2897524376 @default.
• W3216963370 cites W2898106814 @default.
• W3216963370 cites W2905027070 @default.
• W3216963370 cites W2908574415 @default.
• W3216963370 cites W2912510115 @default.
• W3216963370 cites W2921875691 @default.
• W3216963370 cites W2942941240 @default.
• W3216963370 cites W2949370074 @default.
• W3216963370 cites W2958271298 @default.
• W3216963370 cites W2964717223 @default.
• W3216963370 cites W2970536272 @default.
• W3216963370 cites W2977049114 @default.
• W3216963370 cites W2990158495 @default.
• W3216963370 cites W3006479481 @default.
• W3216963370 cites W3013473869 @default.
• W3216963370 cites W3023565412 @default.
• W3216963370 cites W3037465984 @default.
• W3216963370 cites W3059021172 @default.
• W3216963370 cites W3080665560 @default.
• W3216963370 cites W3090233947 @default.
• W3216963370 cites W3092306917 @default.
• W3216963370 cites W3092768944 @default.
• W3216963370 cites W3093384692 @default.
• W3216963370 cites W3101663341 @default.
• W3216963370 cites W3112379209 @default.
• W3216963370 cites W3118317499 @default.
• W3216963370 cites W3132769423 @default.
• W3216963370 cites W3146935595 @default.
• W3216963370 cites W3160126603 @default.
• W3216963370 doi "https://doi.org/10.1136/jitc-2021-002953" @default.
• W3216963370 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/34824158" @default.
• W3216963370 hasPublicationYear "2021" @default.
• W3216963370 type Work @default.
• W3216963370 sameAs 3216963370 @default.
• W3216963370 citedByCount "22" @default.
• W3216963370 countsByYear W32169633702022 @default.
• W3216963370 countsByYear W32169633702023 @default.
• W3216963370 crossrefType "journal-article" @default.
• W3216963370 hasAuthorship W3216963370A5002953299 @default.
• W3216963370 hasAuthorship W3216963370A5023079672 @default.
• W3216963370 hasAuthorship W3216963370A5025411417 @default.
• W3216963370 hasAuthorship W3216963370A5029243551 @default.
• W3216963370 hasAuthorship W3216963370A5029398481 @default.
• W3216963370 hasAuthorship W3216963370A5039064555 @default.
• W3216963370 hasAuthorship W3216963370A5046450040 @default.
• W3216963370 hasAuthorship W3216963370A5048677608 @default.

• next